AI

Akshay Indravadan Joshi

Active Director Director DIN 11088117
DIN 11088117 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Akshay Indravadan Joshi

Data last updated:

Akshay Indravadan Joshi is a Director at Axiora Pharmaceutical Private Limited (since 2025) and Director at Resiidier Healthcare Private Limited (since 2025).

DIN 11088117
Primary Designation Director
First Appointment 13 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Jul 20252025Active
Resiidier Healthcare Private Limited U86100GJ2025PTC162857
Director13 May 20252025Active

Directorship timeline

Open interactive timeline →
Axiora Pharmaceutical Private Limited
Resiidier Healthcare Private Limited
Premium access

Shareholding and investment profile for Akshay Indravadan Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akshay Indravadan Joshi

Akshay Indravadan Joshi currently holds 2 directorships: Axiora Pharmaceutical Private Limited (Director, since 04 Jul 2025); Resiidier Healthcare Private Limited (Director, since 13 May 2025).

Akshay Indravadan Joshi was first appointed on 13 May 2025 as Director at Resiidier Healthcare Private Limited.

The current boards of Akshay Indravadan Joshi's companies include Priyank Hemangbhai Vasavada (Axiora Pharmaceutical Private Limited), Kajalben Shyamalbhai Patel (Resiidier Healthcare Private Limited), Sagar Rajendrabhai Jani (Resiidier Healthcare Private Limited), Shraddha Sagarbhai Jani (Resiidier Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available